CUSIP No. 293594107
13G
Item 1(a). | Name of Issuer: |
Enovix Corporation (the “Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
3501 W. Warren Avenue
Fremont, CA, 94538
Item 2(a). | Name of Person Filing: |
This joint statement on Schedule 13G is being filed by Eclipse Fund III, L.P. (“Eclipse III”), Eclipse GP III, LLC (“Eclipse GP III” and together with Eclipse III, the “Reporting Entities”) and Lior Susan (“Mr. Susan”). The Reporting Entities and Mr. Susan collectively are referred to as the “Reporting Persons”.
Item 2(b) | Address of Principal Business Office, or if None, Residence: |
The address of the principal business office of each Reporting Person is 514 High Street, Suite 4, Palo Alto, California 94301.
Eclipse GP III is a limited liability company organized under the laws of the State of Delaware. Eclipse III is a limited partnership organized under the laws of the State of Delaware. Mr. Susan is a citizen of the United States of America.
Item 2(d). | Title of Class of Securities: |
Common Stock, $0.001 par value per share (“Common Stock”).
293594107
Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
(a) Amount beneficially owned:
See Row 9 of the cover page for each Reporting Person. Eclipse III is the record owner of 17,583,258 shares of Common Stock (the “Eclipse III Shares”). As the general partner of Eclipse III, Eclipse GP III may be deemed to beneficially own the Eclipse III Shares. As the managing member of Eclipse GP III, Mr. Susan also may be deemed to beneficially own the Eclipse III Shares.
(b) Percent of class:
See Row 11 of the cover page for each Reporting Person and the corresponding footnotes.*